During the past decade, Eye Institute Limited conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Eye Institute Limited" are "Geographic Atrophy" (1 trials) and "Open Angle Glaucoma" (1 trials). Many other conditions were trialed in "Eye Institute Limited" in a lesser frequency.

Most popular intervention types in "Eye Institute Limited" are "Drug" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "ONL1204 Ophthalmic solution" (1 trials), "ONL1204 Ophthalmic solution (Dose A)" (1 trials), "ONL1204 Ophthalmic solution (Dose B)" (1 trials), "Sham procedure" (1 trials) and "sham injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eye Institute Limited" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Eye Institute Limited". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Eye Institute Limited, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Eye Institute Limited, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".